A risk‐based approach to managing active pharmaceutical ingredients in manufacturing effluent-Reference-Cited by-同舟云学术

A risk‐based approach to managing active pharmaceutical ingredients in manufacturing effluent

Published:2015-11-18 Issue:4 Volume:35 Page:813-822
ISSN:0730-7268
Container-title:Environmental Toxicology and Chemistry
language:en
Short-container-title:Environ Toxicol Chem

Author:

Caldwell Daniel J.¹,Mertens Birgit²,Kappler Kelly³,Senac Thomas⁴,Journel Romain⁴,Wilson Peter⁵,Meyerhoff Roger D.⁶,Parke Neil J.⁶,Mastrocco Frank⁷,Mattson Bengt⁸,Murray‐Smith Richard⁹,Dolan David G.¹⁰,Straub Jürg Oliver¹¹,Wiedemann Michael¹²,Hartmann Andreas¹³,Finan Douglas S.¹⁴

Affiliation:

1. Johnson & JohnsonNew BrunswickNJUSA

2. Janssen Pharmaceutical Companies of Johnson & JohnsonBeerseBelgium

3. Johnson & Johnson Consumer Group of CompaniesSkillmanNew JerseyUSA

4. SanofiParisFrance

5. Sanofi BridgewaterNew JerseyUSA

6. Eli LillyIndianapolisIndianaUSA

7. PfizerNew YorkNew YorkUSA

8. LIF, Swedish Association of the Pharmaceutical IndustryStockholmSweden

9. AstraZenecaAlderley ParkUnited Kingdom

10. AmgenThousand OaksCaliforniaUSA

11. F. Hoffmann‐La RocheBaselSwitzerland

12. Bayer HealthCareLeverkusenGermany

13. NovartisBaselSwitzerland

14. GSK, Research Triangle ParkNorth CarolinaUSA

Funder

Whitehouse Station, NJ, USA

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Environmental Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/etc.3163

Reference57 articles.

1. Occurrence and Fate of Human Pharmaceuticals in the Environment

2. Landfill disposal of unused medicines reduces surface water releases

3. CaldwellDJ.2016. Sources of pharmaceutical residues in the environment and their control. In Hester RE Harrison RM eds Pharmaceuticals in the Environment Vol 41—Issues in Environmental Science and Technology. Royal Society of Chemistry Cambridge UK.

4. Life Cycle Comparison of Environmental Emissions from Three Disposal Options for Unused Pharmaceuticals

5. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: Review of evidence and need for knowledge

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mastering Quality: Uniting Risk Assessment With Quality by Design (QbD) Principles for Pharmaceutical Excellence;Cureus;2024-08-30

2. Statistical computational optimization approach for photocatalytic-ozonation decontamination of metronidazole in aqueous media using CuFe2O4/SiO2/ZnO nanocomposite;Environmental Research;2024-02

3. Removal of pharmaceuticals, cosmetics, and toiletries from water by nanomaterials;Nanotechnology to Monitor, Remedy, and Prevent Pollution;2024

4. Biodegradation of pharmaceutical compounds in industrial wastewater using biological treatment: a comprehensive overview;International Journal of Environmental Science and Technology;2023-03-15

5. Sustainability Assessment of Industrial Production of Pharmaceuticals Through a Life Cycle Assessment Approach;Journal of Hazardous, Toxic, and Radioactive Waste;2022-10